Gomez-Soler et al., 2019 - Google Patents
Engineering nanomolar peptide ligands that differentially modulate EphA2 receptor signalingGomez-Soler et al., 2019
View HTML- Document ID
- 7762110977498152805
- Author
- Gomez-Soler M
- Gehring M
- Lechtenberg B
- Zapata-Mercado E
- Hristova K
- Pasquale E
- Publication year
- Publication venue
- Journal of Biological Chemistry
External Links
Snippet
The EPH receptor A2 (EphA2) tyrosine kinase plays an important role in a plethora of biological and disease processes, ranging from angiogenesis and cancer to inflammation and parasitic infections. EphA2 is therefore considered an important drug target. Two short …
- 230000027455 binding 0 title abstract description 113
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gomez-Soler et al. | Engineering nanomolar peptide ligands that differentially modulate EphA2 receptor signaling | |
| Rana et al. | Fatty acyl recognition and transfer by an integral membrane S-acyltransferase | |
| McGrath et al. | LRRK2 binds to the Rab32 subfamily in a GTP-dependent manner via its armadillo domain | |
| Rangarajan et al. | The cytoskeletal protein α-catenin unfurls upon binding to vinculin | |
| Tanaka et al. | Design and characterization of bivalent BET inhibitors | |
| Hübner et al. | Structure-guided development of heterodimer-selective GPCR ligands | |
| Herrmann et al. | Sequence of interactions in receptor-G protein coupling | |
| Qin et al. | Structural characterization of the EphA4-Ephrin-B2 complex reveals new features enabling Eph-ephrin binding promiscuity | |
| Wu et al. | Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists | |
| Zhou et al. | Identification of SRC3/AIB1 as a Preferred Coactivator for Hormone-activated Androgen Receptor*♦ | |
| Lüscher et al. | Cl− as a bona fide signaling ion | |
| Kallen et al. | Crystal structure of human estrogen-related receptor α in complex with a synthetic inverse agonist reveals its novel molecular mechanism | |
| Gianni et al. | The kinetics of PDZ domain-ligand interactions and implications for the binding mechanism | |
| Oswald et al. | Crystal structures of the choline/acetylcholine substrate-binding protein ChoX from Sinorhizobium meliloti in the liganded and unliganded-closed states | |
| Davis et al. | Structural and molecular characterization of a preferred protein interaction surface on G protein βγ subunits | |
| Deluigi et al. | Complexes of the neurotensin receptor 1 with small-molecule ligands reveal structural determinants of full, partial, and inverse agonism | |
| Kusano et al. | Structural basis for extracellular interactions between calcitonin receptor‐like receptor and receptor activity‐modifying protein 2 for adrenomedullin‐specific binding | |
| Kimple et al. | Structural determinants of G-protein α subunit selectivity by regulator of G-protein signaling 2 (RGS2) | |
| Pocanschi et al. | Structural and functional relationships between the lectin and arm domains of calreticulin | |
| Diskowski et al. | Functional diversity of the superfamily of K+ transporters to meet various requirements | |
| Wiesmann et al. | Crystal structure of the complex between VEGF and a receptor-blocking peptide | |
| Hu et al. | Structural basis for the interaction between the Golgi reassembly-stacking protein GRASP65 and the Golgi matrix protein GM130 | |
| Ghosh et al. | Receptor-and nucleotide exchange-independent mechanisms for promoting G protein subunit dissociation | |
| Chen et al. | Phe310 in transmembrane VI of the α1B-adrenergic receptor is a key switch residue involved in activation and catecholamine ring aromatic bonding | |
| Li et al. | Structural basis for ligand reception by anaplastic lymphoma kinase |